ÂÜÀòÂÒÂ×

Edward Tumaian has a strong background in clinical operations, with leadership roles at various companies including Cyclo Therapeutics, Inc., CytoSorbents Corporation, and Parexel. Edward also held Vice President positions at Imaging Endpoints and TFS - Clinical Contract Research Organization, where they were responsible for overseeing global clinical development. Prior to their Vice President roles, Edward held management positions at Quintiles, Alcon Laboratories, Inc., PPD, Novartis, and Sanofi-Synthelabo, where they managed clinical research, study operations, and vendor relationships.

Edward Tumaian pursued a Bachelor of Science degree in Biology, General at Villanova University.